Cargando…
Which is the optimal management for locally advanced gastric cancer patients with TRG 0 and 1 after R0 resection?
BACKGROUND: Neoadjuvant chemotherapy (NAC) followed by surgery currently offers promise as a strategy for patients with locally advanced gastric cancer (GC). However, there is limited evidence to guide treatment for TRG 0 and 1 patients with locally advanced GC after R0 resection. This study set out...
Autores principales: | Ma, Fei, Zhang, Yonglei, Peng, Liangqun, Zhang, Zhandong, Yang, Wei, Chai, Junhui, Zhang, Bin, Ji, Sheqing, Hua, Yawei, Chen, Xiaobing, Luo, Suxia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7475443/ https://www.ncbi.nlm.nih.gov/pubmed/32953748 http://dx.doi.org/10.21037/atm-20-3986 |
Ejemplares similares
-
Various Kinds of Functional Digestive Tract Reconstruction Methods After Proximal Gastrectomy
por: Lu, Shuaibing, et al.
Publicado: (2021) -
Short-term outcomes of laparoscopic versus open proximal gastrectomy with double-tract reconstruction for Siewert type II and III adenocarcinoma of the esophagogastric junction: a retrospective observational study of consecutive patients
por: Ma, Fei, et al.
Publicado: (2021) -
LncRNA MSC-AS1 Is a Diagnostic Biomarker and Predicts Poor Prognosis in Patients With Gastric Cancer by Integrated Bioinformatics Analysis
por: Yang, Wei, et al.
Publicado: (2021) -
Corrigendum: LncRNA MSC-AS1 Is a Diagnostic Biomarker and Predicts Poor Prognosis in Patients With Gastric Cancer by Integrated Bioinformatics Analysis
por: Yang, Wei, et al.
Publicado: (2022) -
PHF5A facilitates the development and progression of gastric cancer through SKP2-mediated stabilization of FOS
por: Zhang, Zhandong, et al.
Publicado: (2023)